Amicus Therapeutics Inc (NASDAQ:FOLD)
| 9.96 BATS BZX Real-Time Price As of 10:17am ET |  -0.15 / -1.48%Today’s Change | 7.11 Today|||52-Week Range 14.62 | +3.97% Year-to-Date |
Latest FOLD News | Press Releases
No recent news for Amicus Therapeutics Inc.
Today’s Trading
| Previous close | 10.11 |
| Today’s open | 10.06 |
| Day’s range | 9.94 - 10.06 |
| Volume | 313,897 |
| Average volume (3 months) | 3,611,497 |
| Market cap | $2.6B |
Data as of 10:17am ET, 12/09/2019
Growth & Valuation
| Earnings growth (last year) | -1.54% |
| Earnings growth (this year) | +26.67% |
| Earnings growth (next 5 years) | +43.45% |
| Revenue growth (last year) | +147.08% |
| P/E ratio | NM |
| Price/Sales | 19.51 |
| Price/Book | 5.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RAREUltragenyx Pharmaceu... | -0.10 | -0.23% |
| ARNAArena Pharmaceutical... | +0.67 | +1.39% |
| AGIOAgios Pharmaceutical... | +3.61 | +8.82% |
| BHVNBiohaven Pharmaceuti... | -0.05 | -0.09% |
Data as of 10:17am ET, 12/09/2019
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $91.2M |
| Annual profit (last year) | -$349.0M |
| Net profit margin | -382.48% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cranbury, New Jersey |
Forecasts
